Search

Search Constraints

You searched for: Author/Creator McDermott, David F

Search Results

21. Phase Ib dose-finding study of axitinib plus pembrolizumab in treatment-naïve patients with advanced renal cell carcinoma. (4th November 2015)

22. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Issue 2 (11th November 2020)

23. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Issue 2 (11th November 2020)

24. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Issue 2 (11th November 2020)

25. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Issue 2 (11th November 2020)

26. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Issue 2 (11th November 2020)

27. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Issue 2 (11th November 2020)

28. Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma. Issue 2 (11th November 2020)

29. Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study. Issue 1 (22nd October 2018)